In March, Nevada lawmakers introduced a psilocybin and MDMA research bill, and the Missouri House of Representatives approved a psilocybin research bill. While cannabis studies continue to grow, the number of psilocybin research efforts have been growing. The department would be limited to spending a maximum of 2% of the money for psilocybin grant research each fiscal year. In February, city officials in Ferndale, Michigan voted to decriminalize mushrooms as well as other psychedelic substances such as DMT and ayahuasca, and Utah officials introduced a psilocybin bill. On February 13, legislators unanimously passed a different psilocybin research bill in the House Military Affairs & Public Safety Committee, which would have given $30 million in grants to psilocybin researchers. “Today HB 2486 (clinical research; psilocybin; grants; appropriation) passed MAPS Committee by a unanimous vote of 15-0!
Arizona senators voted to approve a general appropriations act 2023-2024 on May 10. Within the appropriations bill is a multitude of funding proposals from the governor’s office, which includes everything from Alzheimer’s disease research ($4.1 million), a newborn screening program ($12 million), and the Arizona nurse education investment pilot program ($15 million), but it also includes $5 million earmarked for psilocybin research.
A health...
Read the full article @ High Times